Sanofi reinforces its presence in Morocco

PR Newswire/Les Echos/ 
PRESS RELEASE 


                  Sanofi reinforces its presence in Morocco
          - Inauguration of a new EUR20 million logistics platform - 
      - Three collaboration agreements signed with the Ministries of 
                            Industry and Health -

Paris, France - April 17, 2013 - Sanofi (EURONEXT: SAN and NYSE: SNY) 
announced today the opening of its new logistics hub in Casablanca, Morocco, 
during a ceremony attended by Christopher A. Viehbacher, CEO of Sanofi, 
Mahsoussi El Aid, General Secretary of Trade, Ministry of Trade, Industry and 
New Technologies, and El Houssaine Louardi, Minister of Health of the Kingdom 
of Morocco.

During the ceremony, Sanofi-Aventis Maroc, Sanofi-Aventis Group, the Ministry 
of Trade, Industry and New Technologies, and the Ministry of Health of the 
Kingdom of Morocco also signed three collaboration agreements intended to 
improve the care of patients with type I diabetes, those suffering from mental 
disorders and epilepsy, and training for careers in the pharmaceutical industry.

"I am very pleased to inaugurate the new Sanofi logistics hub in Morocco, 
which represents an investment of EUR20 million. It will become the largest
distribution center for Sanofi's pharmaceutical products on the African
continent," said Christopher A. Viehbacher, CEO of Sanofi. "As medicines alone
cannot fight such diseases as diabetes, mental disorders and epilepsy, the
collaborations signed today reinforce Sanofi's commitment in building major
programs with stakeholders in the public and private sectors to provide
solutions for prevention, awareness and diagnosis for the benefit of
patients."

Sanofi has been present in Morocco for over 50 years and is the market leader 
in the country.
                                  ***

About the new logistics platform Ain Sebâa - Casablanca, Morocco
The new Sanofi distribution center in Morocco covers an area of nearly 12,000
square meters and has a capacity for 14,500 pallets. It handles 1,300 product
references produced by the Moroccan subsidiary, both exported to sub-Saharan
Africa and destined for the Moroccan and import market. This state-of-the-art
distribution center combines new technologies, advanced services and respect 
for the environment.

About the collaboration agreements
The collaboration agreement entered into between Sanofi-Aventis Maroc and the
Ministry of Health, signed for a period of three years, will be devoted to type
I diabetes, with the aim of developing standard care protocols for children and
adolescents with diabetes. This will involve the introduction of a standardized
therapeutic education program, upgrading the eleven existing centers for
pediatric diabetology consultation, creating two new centers in Oujda and
Agadir, and training health professionals and paramedical staff to take care of
children and adolescents with diabetes.

The second collaboration agreement entered into between Sanofi-Aventis Group 
(in particular the Access to medicines department), Sanofi-Aventis Maroc and 
the Ministry of Health, for a term of five years, will be devoted to mental
disorders and epilepsy. The aim is to reinforce care facilities for people with
these diseases in Morocco by training 40 psychiatrists, 40 neurologists, 160
general practitioners (GPs) and 160 nurses, and raising awareness about these
conditions among the Moroccan people.

Under the third collaboration agreement entered into between Sanofi-Aventis
Maroc, the Ministry of Trade, Industry and New Technologies and the Ministry of
Health, Sanofi-Aventis Maroc will contribute to the National Contract Program
which outlines a general framework for the development of the Moroccan
pharmaceutical industry. Sanofi-Aventis Maroc will provide with the training 
of agents, technicians and managers working in the Ministry of Health in 
connection with careers in the pharmaceutical industry and more specifically 
with respect to Best Distribution Practices, Health, Safety and the 
Environment, and supply chain.

About Sanofi in Morocco
Sanofi has been present in Morocco for over 50 years and is the market leader 
in the country. It has a workforce of 900 people, including the Maphar 
production site, a pharmaceutical development center, and a new logistics 
platform. The Maphar production site, located in Zenata, Casablanca, is 
certified by the World Health Organization and produced 70 million units in 
2012, including 20 million units of the malaria treatment ASAQ Winthrop(r). 
Sanofi's activities in Morocco include registering, producing, distributing 
and marketing pharmaceutical products (including innovative, traditional, and 
generic medicines, vaccines and consumer-health products) as well as dietary 
products and medical devices.www.sanofi.ma, www.maphar.ma 

About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, consumer healthcare, emerging
markets, animal health and the new Genzyme. Sanofi is listed in Paris 
(EURONEXT: SAN) and in New York (NYSE: SNY). www.sanofi.com 

Contacts:

Press Relations                   Investor Relations
Frédéric Lemonde-San              Sébastien Martel
Tel.: + (33) 1 53 77 91 55        Tel.: + (33) 1 53 77 45 45
frederic.lemonde @ sanofi.com     ir@sanofi.com


                  
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Apr/17/2013 13:26 GMT